Top

Published in:

01-11-2014 | Research Article

HOXD10 expression in human breast cancer

Authors: N. V. Vardhini, P. Jagan Mohan Rao, P. Balakrishna Murthy, G. Sudhakar

Published in: Tumor Biology | Issue 11/2014

Abstract

Breast cancer is the most frequent malignancy among females. In this study, we analyzed the expression pattern of a homeobox gene (HOXD10) in human invasive ductal breast cancer tissues and normal tissues. With the ACTB (β-actin) gene as a reference, HOXD10 was detected in 60 breast cancer tissues by using the quantitative real-time PCR (qPCR) method with the Relative Expression Software Tool (REST). We found that the HOXD10 expression level was significantly different between cancerous and normal tissues. Downregulation of the HOXD10 gene expression was examined in high-grade samples. Low-grade tissue showed no difference from the control group. HOXD10 expression was reduced in grade II breast carcinoma tissues. This data reveal that misexpression of the HOXD10 gene supports the development and involvement in breast cancer and may serve as a potential biomarker for the diagnosis of human ductal invasive breast carcinoma.

Globocan 2012;http://globocan.iarc.fr

Murthy NS, Chaudhry K, Nadayil D, Agarwal UK, Saxena S. The changing trends of breast cancer, the Indian scenario. Indian Journal Of Cancer National Cancer Registry Programme ICMR, Division of Non-Communicable Diseases, Indian Council of Medical Research. Indian J Cancer. 2009;46:73–7.PubMedCrossRef

Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA. 2003;289:1421–4.PubMedCrossRef

van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530–6.CrossRef

Sotiriou C, Pusztai L. Gene expression signatures in breast cancer. N Engl J Med. 2009;360:790–800.PubMedCrossRef

Krumlauf R. Hox genes in vertebrate development. Cell. 1994;70:191–201.CrossRef

Zakany J, Kmita M, Duboule D. A dual role for Hox genes in limb anterior-posterior asymmetry. Science. 2004;304:1669–72.PubMedCrossRef

Redline RW, Williams AJ, Patterson P, Collins T. Human HOX4E, A gene strongly expressed in the adult male and female urogenital tracts. Genomics. 1992;13:425–30.PubMedCrossRef

Abate-Shen C. Deregulated homeobox gene expression in cancer, cause or consequence? Nat Rev Cancer. 2002;2:777–85.PubMedCrossRef

10.

Samuel S, Naora H. Homeobox gene expression in cancer, insights from developmental regulation and deregulation. Eur J Cancer. 2005;41:2428–37.PubMedCrossRef

11.

Robson EJ, He SJ, Eccles MR. A panorama of PAX genes in cancer and development. Nat Rev Cancer. 2006;6:52–62.PubMedCrossRef

12.

Osborne J, Hu C, Hawley C, et al. Expression of HOXD10 gene in normal endometrium and endometrial adenocarcinoma. J Soc Gynecol Invest. 1998;5:277–80.CrossRef

13.

Makiyama K, Hamada J, Takada M. Aberrant expression of HOX genes in human invasive breast carcinoma. Oncol Rep. 2005;13:673–9.PubMed

14.

Redline RW, Hudock P, MacFee M, Patterson P. Expression of AbdB-type homeobox genes in human tumors. Lab Invest. 1994;71:663–70.PubMed

15.

Miller GJ, Miller HL. Adrie van Bokhoven Lambert JR, Priya, N, Werahera OS, Scott Lucia M, Steven K N et al. Aberrant HOXC expression accomplishes the malignant phenotype in human prostate. Cancer Res. 2003;63:5879–88.PubMed

16.

Cantile M, Pettinato G, Procino A, Feliciello I, Cindolo L, Cillo C. In vivo expression of the whole HOX gene network in human breast cancer. Eur J Cancer. 2003;39:257–64.PubMedCrossRef

17.

Cantile M, Schiavo G, Terracciano L, Cillo C. The HOX gene network as a potential target for cancer therapy. Current Cancer Therapy Reviews. 2007;3:17–24.CrossRef

18.

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^ΔΔCT method. Methods. 2001;25:402–8.PubMedCrossRef

19.

Sobin LH, and Witterkind C(eds.). TNM classification of malignant tumours. 6th edition. Wiley-Liss, New York: 2002; 131–141.

20.

Olson J. Bathsheba’s breast: women, cancer, and history. Baltimore: John Hopkins Press; 2002.

21.

Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucl Acids Res. 2002;30:e36.PubMedCentralPubMedCrossRef

22.

Derveaux S, Vandesompele J, Hellemans. How to do successful gene expression analysis using real-time PCR. J Appl Meteorol. 2010;50:227–30.

23.

Goetz MP et al. A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen. Clin Cancer Res. 2006;12:2080–7.PubMedCrossRef

24.

Jansen MP et al. HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study. J Clin Oncol. 2007;25:662–8.PubMedCrossRef

25.

Chou WC et al. Acute myeloid leukemia bearing t (7; 11) (p15; p15) is a cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients. Leukemia. 2009;23:1303–10.PubMedCrossRef

26.

Hedlund E, Karsten SL, Kudo L, Geschwind DH, Carpenter EM. Identification of a Hoxd10-regulated transcriptional network and combinatorial interactions with Hoxa10 during spinal cord development. J Neurosci Res. 2004;75:307–19.PubMedCrossRef

27.

Carrio M, Arderiu G, Myers C, Boudreau NJ. Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model. Cancer Res. 2005;65:7177–85.PubMedCrossRef

28.

Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449:682–8.PubMedCrossRef

29.

Sun L et al. MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res. 2011;1389:9–18.PubMedCrossRef

30.

Wang L et al. Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis. Mol Med. 2012;18:389–400.PubMedCentralPubMed

31.

Hu X, Chen D, Cui Y, Li Z, Huang J. Targeting microRNA-23a to inhibit glioma cell invasion via HOXD10. Scientific Reports. 2013;3:3423.PubMedCentralPubMed

Title: HOXD10 expression in human breast cancer
Authors: N. V. Vardhini
P. Jagan Mohan Rao
P. Balakrishna Murthy
G. Sudhakar
Publication date: 01-11-2014
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 11/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-014-2324-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2014

Primary epidural hemangiopericytoma in the sacrum: a rare case and literature review

NBS1 Glu185Gln polymorphism and susceptibility to urinary system cancer: a meta-analysis

Over-expression of TRPM8 is associated with poor prognosis in urothelial carcinoma of bladder

Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein

Expression and clinical significance of microRNA-152 in supragalottic laryngeal carcinoma

Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest

Keynote webinar | Spotlight on antibody–drug conjugates in cancer